M53 Primary Aldosteronism and Cardiometabolic Risk: Approach to Medical Management

Program: Meet-the-Professor Sessions
Clinical Session
Monday, April 4, 2016: 9:00 AM-9:45 AM
Room 205 (BCEC)
Speaker:
Gail K Adler, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Nothing to Disclose: GKA

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire